These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 15793820)
1. Immune responses in mice of beta-galactosidase adsorbed or encapsulated in poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres. Stivaktakis N; Nikou K; Panagi Z; Beletsi A; Leondiadis L; Avgoustakis K J Biomed Mater Res A; 2005 Jun; 73(3):332-8. PubMed ID: 15793820 [TBL] [Abstract][Full Text] [Related]
2. PLA and PLGA microspheres of beta-galactosidase: Effect of formulation factors on protein antigenicity and immunogenicity. Stivaktakis N; Nikou K; Panagi Z; Beletsi A; Leondiadis L; Avgoustakis K J Biomed Mater Res A; 2004 Jul; 70(1):139-48. PubMed ID: 15174118 [TBL] [Abstract][Full Text] [Related]
3. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination. Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180 [TBL] [Abstract][Full Text] [Related]
4. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers. Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673 [TBL] [Abstract][Full Text] [Related]
5. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release. Kim HK; Park TG J Control Release; 2004 Jul; 98(1):115-25. PubMed ID: 15245894 [TBL] [Abstract][Full Text] [Related]
6. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres. Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228 [TBL] [Abstract][Full Text] [Related]
7. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Alonso MJ; Gupta RK; Min C; Siber GR; Langer R Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550 [TBL] [Abstract][Full Text] [Related]
8. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Jackson JK; Hung T; Letchford K; Burt HM Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895 [TBL] [Abstract][Full Text] [Related]
9. Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice. Mohanan D; Gander B; Kündig TM; Johansen P Eur J Pharm Biopharm; 2012 Feb; 80(2):274-81. PubMed ID: 22024408 [TBL] [Abstract][Full Text] [Related]
10. Biodegradable poly-l-lactide based microparticles as controlled release delivery system for filarial vaccine candidate antigens. Anugraha G; Madhumathi J; Jeya Prita PJ; Kaliraj P Eur J Pharmacol; 2015 Jan; 747():174-80. PubMed ID: 25514604 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres. Xu FH; Zhang Q Yao Xue Xue Bao; 2007 Jan; 42(1):1-7. PubMed ID: 17520799 [TBL] [Abstract][Full Text] [Related]
12. Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. Wang D; Robinson DR; Kwon GS; Samuel J J Control Release; 1999 Jan; 57(1):9-18. PubMed ID: 9863034 [TBL] [Abstract][Full Text] [Related]
13. Improved immunogenicity of biodegradable polymer particles entrapped rotavirus vaccine. Nayak B; Ray AR; Panda AK; Ray P J Biomater Appl; 2011 Jan; 25(5):469-96. PubMed ID: 20207774 [TBL] [Abstract][Full Text] [Related]
14. Safety evaluation of poly(lactic-co-glycolic acid)/poly(lactic-acid) microspheres through intravitreal injection in rabbits. Rong X; Yuan W; Lu Y; Mo X Int J Nanomedicine; 2014; 9():3057-68. PubMed ID: 25028546 [TBL] [Abstract][Full Text] [Related]
15. Enhanced humoral and cell-mediated immune responses generated by cationic polymer-coated PLA microspheres with adsorbed HBsAg. Chen X; Liu Y; Wang L; Liu Y; Zhang W; Fan B; Ma X; Yuan Q; Ma G; Su Z Mol Pharm; 2014 Jun; 11(6):1772-84. PubMed ID: 24738485 [TBL] [Abstract][Full Text] [Related]
16. A simple and robust method for pre-wetting poly (lactic-co-glycolic) acid microspheres. Wright B; Parmar N; Bozec L; Aguayo SD; Day RM J Biomater Appl; 2015 Aug; 30(2):147-59. PubMed ID: 25791685 [TBL] [Abstract][Full Text] [Related]
17. Delivery of MUC1 mucin peptide by Poly(d,l-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses. Newman KD; Sosnowski DL; Kwon GS; Samuel J J Pharm Sci; 1998 Nov; 87(11):1421-7. PubMed ID: 9811500 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy. Lim SM; Eom HN; Jiang HH; Sohn M; Lee KC J Pharm Sci; 2015 Jan; 104(1):72-80. PubMed ID: 25407390 [TBL] [Abstract][Full Text] [Related]
19. Use of encapsulated single chain antibodies for induction of anti-idiotypic humoral and cellular immune responses. Ma J; Luo D; Kwon GS; Samuel J; Noujaim AA; Madiyalakan R J Pharm Sci; 1998 Nov; 87(11):1375-8. PubMed ID: 9811493 [TBL] [Abstract][Full Text] [Related]
20. Ovalbumin peptide encapsulated in poly(d,l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response. Newman KD; Samuel J; Kwon G J Control Release; 1998 Jun; 54(1):49-59. PubMed ID: 9741903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]